Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York, USA.
FASEB J. 2013 Aug;27(8):3229-38. doi: 10.1096/fj.13-229138. Epub 2013 May 6.
The Na(+)/I(-) symporter (NIS) is a plasma membrane glycoprotein that mediates active I(-) transport in the thyroid, the first step in the biosynthesis of the iodine-containing thyroid hormones T3 and T4. Several NIS mutants have been identified as a cause of congenital I(-) transport defect (ITD), and their investigation has yielded valuable mechanistic information on NIS. Here we report a thorough characterization of the ITD-causing NIS mutation in which the sixth intracellular loop residues 439-443 are missing. This mutant protein was intracellularly retained, incompletely glycosylated, and intrinsically inactive. Engineering 5 Ala at positions 439-443 partially recovered cell surface targeting and activity (∼15%). Strikingly, NIS with the sequence 439-AANAA-443, in which Asn was restored at position 441, was targeted to the plasma membrane and exhibited ∼95% the transport activity of WT NIS. Based on our NIS homology model, we propose that the side chain of N441, a residue conserved throughout most of the SLC5 family, interacts with the main chain amino group of G444, capping the α-helix of transmembrane segment XII and thus stabilizing the structure of the molecule. Our data provide insight into a critical interhelical interaction required for NIS folding and activity.
钠/碘同向转运体(NIS)是一种位于细胞膜上的糖蛋白,介导甲状腺中的碘负离子主动转运,这是碘代甲状腺素 T3 和 T4 生物合成的第一步。已经鉴定出几种 NIS 突变体是先天性碘负离子转运缺陷(ITD)的原因,对它们的研究为 NIS 的机制提供了有价值的信息。在这里,我们全面描述了导致 ITD 的 NIS 突变,其中第六个细胞内环残基 439-443 缺失。这种突变蛋白在细胞内被保留,不完全糖基化,并且固有地无活性。在位置 439-443 处设计 5 个 Ala 可部分恢复细胞表面靶向和活性(约 15%)。引人注目的是,具有 439-AANAA-443 序列的 NIS 中,在位置 441 恢复了 Asn,被靶向到质膜,并表现出 WT NIS 约 95%的转运活性。基于我们的 NIS 同源模型,我们提出 N441 侧链(该残基在大多数 SLC5 家族中都保守)与跨膜片段 XII 的主链氨基基团相互作用,从而封闭了α-螺旋并稳定了分子的结构。我们的数据为 NIS 折叠和活性所需的关键跨膜相互作用提供了深入的了解。